| Avecho Biotechnology Limited (AVE) ORDINARY FULLY PAID |
Health Care |
$46 |
March 2026 Quarterly Activities Report & Appendix 4C
|
29 Apr 2026 8:33AM |
$0.011 |
$0.012 |
risen by
9.09%
|
|
AVE - Price-sensitive ASX Announcement
Full Release
Key Points
- Avecho's Phase III CBD insomnia trial update.
- Licensing agreement with Sandoz AG includes milestone payments and royalties.
- Projected growth in the Australian CBD market and global insomnia therapeutics market.
- CEO presentations at healthcare conferences.
- Financial activities and cash flow statements for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prospect Resources Limited (PSC) ORDINARY FULLY PAID |
Materials |
$266 |
Further Impressive Gold Results from Nyungu Central
|
29 Apr 2026 8:32AM |
$0.315 |
$0.320 |
risen by
1.59%
|
|
PSC - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant gold mineralisation confirmed at Nyungu Central.
- Notable gold assay results from various drill holes have been reported.
- The gold re-assay programme includes 59 holes, with results pending for some.
- There is strong potential to upgrade Mumbezhi Copper Project economics with gold and cobalt credits.
- An updated Mineral Resource Estimate (MRE) for Nyungu Central is expected in Q2 2026.
- Phase 3 drilling at Mumbezhi to commence in early May focusing on regional growth targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RocketDNA Ltd (RKT) ORDINARY FULLY PAID |
Information Technology |
$29 |
Investor Presentation - April 2026
|
29 Apr 2026 8:30AM |
$0.023 |
$0.024 |
risen by
4.35%
|
|
| Odyssey Gold Ltd (ODY) ORDINARY FULLY PAID |
Materials |
$49 |
March 2026 Quarterly Report
|
29 Apr 2026 8:29AM |
$0.037 |
$0.035 |
fallen by
5.41%
|
|
ODY - Price-sensitive ASX Announcement
Full Release
Key Points
- Odyssey Gold Ltd commenced 2026 field work at Tuckanarra Gold Project.
- A reverse circulation drill rig began resource definition drilling at key deposits.
- A Scoping Study is underway to update Mineral Resource Estimate.
- Current MRE at Tuckanarra is 5.14Mt @ 2.5g/t for 407,000oz of gold.
- A Native Vegetation Clearing Permit application was lodged in April 2026.
- Company raised $9.0 million through a share placement.
- Engagement with regional processing plants for a low-cost production pathway.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TrivarX Ltd (TRI) ORDINARY FULLY PAID |
Health Care |
$29 |
Dr Danielle Meyrick appointed as CEO
|
29 Apr 2026 8:29AM |
$0.016 |
$0.025 |
risen by
56.25%
|
|
TRI - Price-sensitive ASX Announcement
Full Release
Key Points
- Dr Danielle Meyrick appointed as CEO effective 1 June 2026
- TrivarX Ltd focuses on the Stabl-Im platform for imaging solutions
- Dr Meyrick has over 20 years of experience in related fields
- Her previous roles include positions at Telix Pharmaceuticals and ITM Isotopes
- Stabl-Im utilizes stable isotope labelling for non-invasive imaging
- Dr Meyrick's remuneration includes $300,000 salary and performance incentives
- Company aims for clinical and regulatory advancements under her leadership
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Toubani Resources Inc (TRE) ORDINARY FULLY PAID |
Materials |
$310 |
Mali Update
|
29 Apr 2026 8:29AM |
$0.435 |
$0.405 |
fallen by
6.90%
|
|
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$68 |
Trading Halt
|
29 Apr 2026 8:29AM |
$0.405 |
$0.375 |
fallen by
7.41%
|
|
LTP - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by LTR Pharma Limited (ASX: LTP) pending data analysis and announcement.
- Halt relates to interim clinical trial results of SPONTAN® Nasal Spray for Erectile Dysfunction.
- Trading halt expected to last until announcement release or trading commencement on 1 May 2026.
- LTR Pharma confirms no awareness of reasons against granting the trading halt.
- LTR Pharma is a pharmaceutical company with a focus on intranasal drug delivery technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cluey Ltd (CLU) ORDINARY FULLY PAID |
Consumer Discretionary |
$2 |
March 2026 Quarterly Actiivities Report and Appendix 4C
|
29 Apr 2026 8:29AM |
$0.020 |
$0.005 |
fallen by
75%
|
|
CLU - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating cash outflow improved to $0.79 million, a 16% reduction from the previous corresponding period.
- Group gross profit margin increased to 58.1%.
- New student growth of 5% in the online tutoring division.
- Release of Stage 1 of AI-driven Cluey+ products.
- Underlying EBITDA loss of $2.11 million, reflecting increased customer acquisition costs.
- Total cash on hand as of 31 March 2026 was $4.81 million.
- Net cash from operating activities was ($0.79) million for Q3 FY26.
- Net cash used in investing activities was ($0.34) million, an increase due to investment in Cluey+.
- Payments to directors and related parties totaled $99,000.
- Customer acquisition costs impacted by 13% inflation in paid search and social media.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GWA Group Limited (GWA) ORDINARY FULLY PAID |
Industrials |
$568 |
Update - Notification of buy-back - GWA
|
29 Apr 2026 8:28AM |
$2.010 |
$2.140 |
risen by
6.47%
|
|
| Vmoto Limited (VMT) ORDINARY FULLY PAID |
Consumer Discretionary |
$48 |
Notice of Annual General Meeting/Proxy Form
|
29 Apr 2026 8:28AM |
$0.110 |
$0.120 |
risen by
9.09%
|
|
| Meteoric Resources NL (MEI) ORDINARY FULLY PAID |
Materials |
$523 |
Completion of $40M Placement
|
29 Apr 2026 8:27AM |
$0.200 |
$0.180 |
fallen by
10%
|
|
MEI - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of $40 million placement
- Issued 235 million new fully paid ordinary shares
- Share price set at $0.17 per share
- Funds will advance the Caldeira Rare Earth Project
- Project aims for a Final Investment Decision in 2026
- Release not for US distribution
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mamba Exploration Limited (M24) ORDINARY FULLY PAID |
Materials |
$11 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Apr 2026 8:27AM |
$0.023 |
$0.022 |
fallen by
4.35%
|
|
M24 - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of a soil sampling program at Meeka East Gold Project.
- Acquisition of 70% interest in Meeka East Gold Project completed.
- Shareholders approved a share placement raising A$2 million.
- Cash balance at quarter-end was $898k with a net operating cash loss of $174k.
- Related party payments totaled $78k for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| McPherson's Limited (MCP) ORDINARY FULLY PAID |
Consumer Staple |
$19 |
Update - Notification of buy-back - MCP
|
29 Apr 2026 8:27AM |
$0.150 |
$0.130 |
fallen by
13.33%
|
|
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,843 |
Update - Notification of buy-back - MGH
|
29 Apr 2026 8:27AM |
$4.700 |
$5.100 |
risen by
8.51%
|
|
| Metal Powder Works Limited (MPW) ORDINARY FULLY PAID |
Industrials |
$256 |
MPW Scales Production 5X to 100MT Annual Capacity
|
29 Apr 2026 8:27AM |
$2.650 |
$2.110 |
fallen by
20.38%
|
|
MPW - Price-sensitive ASX Announcement
Full Release
Key Points
- NextGen machine achieves 100MT annual capacity with over 95% yield.
- DirectPowder™ technology validated at commercial scale.
- Clear pathway to 800MT capacity by 2028 with capital efficiency.
- CAPEX per saleable tonne approximately US$2,600.
- Significant market opportunity in aerospace material specifications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lefroy Exploration Limited (LEX) ORDINARY FULLY PAID |
Materials |
$34 |
March 2026 Quarterly Activities Report
|
29 Apr 2026 8:27AM |
$0.180 |
$0.135 |
fallen by
25%
|
|
LEX - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of diamond drilling at Burns Deposit confirming high-grade gold.
- First gold production from Lucky Strike Gold Mine.
- Ongoing exploration to assess resource extensions at Burns.
- Significant potential for resource growth at Lucky Strike and Burns.
- Stable cash position with ongoing strategic developments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Canterbury Resources Ltd (CBY) ORDINARY FULLY PAID |
Materials |
$16 |
Major Drilling Program Commences at Briggs
|
29 Apr 2026 8:27AM |
$0.033 |
$0.058 |
risen by
75.76%
|
|
CBY - Price-sensitive ASX Announcement
Full Release
Key Points
- Major drilling program commenced at Briggs Copper Project.
- Aimed at upgrading and expanding current MRE as part of PFS.
- Project involves drilling 45 diamond core holes (~14,000m).
- Focus on converting Inferred Resources to Indicated category.
- Testing lateral and depth targets to expand the MRE.
- Obtaining material for metallurgical test work.
- Environmental baseline studies and early-stage engineering conducted in parallel.
- Located near Gladstone with access to infrastructure.
- JV partner Alma Metals Ltd managing the project under an Earn-In Agreement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$31 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Apr 2026 8:26AM |
$0.145 |
$0.110 |
fallen by
24.14%
|
|
EYE - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales for the quarter were US$5.8 million, a 23% increase.
- LTM global sales increased by 24% to US$22 million.
- EBITDA loss improved to US$75,000.
- Record monthly revenue achieved in the USA in March.
- First sales of iTrack™ Advance in China.
- Group cash outflow from operations was A$1.2 million.
- Guidance for FY26 updated to US$21-22 million in sales (excluding China).
- Cash balances at the end of the period were A$1.2 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$4,847 |
March 2026 Quarterly Webcast Presentation
|
29 Apr 2026 8:26AM |
$6.100 |
$5.130 |
fallen by
15.90%
|
|
| Magnum Mining and Exploration Limited (MGU) ORDINARY FULLY PAID |
Materials |
$18 |
Notice of Annual General Meeting/Proxy Form
|
29 Apr 2026 8:26AM |
$0.007 |
$0.006 |
fallen by
21.43%
|
|
| BSP Financial Group Limited (BFL) ORDINARY FULLY PAID |
Financials |
$3,906 |
BFL First Quarter Trading Update 2026
|
29 Apr 2026 8:26AM |
$8.350 |
$8.360 |
risen by
0.12%
|
|
BFL - Price-sensitive ASX Announcement
Full Release
Key Points
- Unaudited NPAT of K278 million, up 14.6% from 1Q25
- Revenue increased by 18.5% to K900 million
- Net interest income grew by 15.9%
- FX income rose 31.4%
- Fee income increased by 16.6%
- Operating expenses rose 22.3% due to investment in growth initiatives
- Capital Adequacy Ratio at 23.9%, above regulatory requirements
- Prudent approach to risk management amid global uncertainties
- Papua New Guinea's grey list status with no significant operational impacts observed
- Commitment to financial inclusion and community support in the South Pacific
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sea Forest Limited (SEA) ORDINARY FULLY PAID |
Consumer Staple |
$112 |
3Q26 Quarterly Update
|
29 Apr 2026 8:26AM |
$2.290 |
$2.390 |
risen by
4.37%
|
|
SEA - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue up 92% to $1.1 million.
- New supply agreements with Avondale Ag and New Agriculture.
- Total cattle under agreement: 131,000.
- Launch of low-carbon Regal Wool Collection with Theory.
- Successful methane reduction pilot.
- Cash balance of $8.4 million and liquidity of $27.4 million.
- Strong growth strategy supported by government policy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lotus Resources Limited (LOT) ORDINARY FULLY PAID |
Energy |
$172 |
Lotus Completes First Phase of Infill Drilling at Letlhakane
|
29 Apr 2026 8:26AM |
$1.470 |
$0.630 |
fallen by
57.14%
|
|
LOT - Price-sensitive ASX Announcement
Full Release
Key Points
- Lotus Resources completed first phase of infill drilling at Letlhakane.
- 71 holes and 4,559 metres drilled in the first phase.
- High-grade uranium intercepts confirmed at Serule West.
- Drilling program aims to upgrade resource categories.
- Metallurgical studies show improved acid consumption.
- Trade-off studies are exploring optimal mining and processing methods.
- Results to be incorporated into updated Mineral Resource Estimate in H2 2026.
- Drilling results confirm uranium mineralisation continuity.
- Letlhakane is one of Lotus Resources' key uranium projects in Botswana.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paradigm Biopharmaceuticals Limited (PAR) ORDINARY FULLY PAID |
Health Care |
$87 |
OARSI Theatre Presentation Showcases iPPS Biomarker Data
|
29 Apr 2026 8:26AM |
$0.195 |
$0.165 |
fallen by
15.38%
|
|
| Strategic Energy Resources Limited (SER) ORDINARY FULLY PAID |
Materials |
$10 |
Review Confirms Potential At Diamantina Copper-Gold Project
|
29 Apr 2026 8:26AM |
$0.215 |
$0.170 |
fallen by
20.93%
|
|
Call 1300 880 160
Start a chat
Schedule a call
